9704 MEDICAL CENTER DRIVE, Rockville, MD
MacroGenics, Inc. Annual Meeting - Stockholder Votes on Director Elections
Reports First Quarter 2026 Financial Results and Highlights Business Transformation
To Sell GMP Manufacturing Operations to Pharmaceuticals
And Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
FDA Removes Partial Clinical Hold on LINNET Study
Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
Other Events
Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership